Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Mol Pharm. 2016 May 26;13(6):2070–2083. doi: 10.1021/acs.molpharmaceut.6b00205

Figure 8.

Figure 8

A wound healing assay was employed to assess the migration of A2780/CDDP, ES2 and IGROV1 cells exposed to media (control), CDDP, DJ-1 siRNA-NP and combinatorial therapy within 48 h. White lines represents cellular migration border.